期刊文献+

505例宫颈癌临床病例分析 被引量:3

The clinical analysis of 505cases of cervical cancer
下载PDF
导出
摘要 目的本研究探讨宫颈癌患者预后相关危险因素,以指导其处理及随访。方法收集北京大学深圳医院近10年间宫颈癌患者505例,研究其临床病理特点与预后的相关因素,采用SPSS 19.0软件分析,P〈0.05为差异有统计学意义。结果①本研究患者发病年龄高峰为35-45岁,呈单峰,3年、5年总体生存率分别为94%、93%;②多因素分析,临床分期、组织分化程度、以铂类为基础的同步化放疗是影响宫颈癌预后的独立危险因素(P〈0.05)。结论本研究患者发病年龄高峰为35-45岁,呈单峰。3年、5年总体生存率高于文献报道。临床分期、组织分化程度、以铂类为基础的同步化放疗是影响宫颈癌预后的独立危险因素。 Objective To evaluate the related risk factors that affect the prognosis of cervical cancer.Methods The clinical data of 505cases of cervical cancer patients who treated in the Department of Gynecologic Oncology of Peking University Shenzhen Hospital in the past 10years were analyzed retrospectively.The clinic pathologic clinicopathologic features and risk factors that related to the prognosis of cervical cancer were analyzed by statistical software SPSS 19.0.A statistically significant difference was indicated by P0.05.Results ① The peak age of onset focus on 35-45years old which showed a single-peak,the 3-year and 5-year survival rates of all patients were 94% and 93%.② The multivariate regression analysis indicated that clinical stage,histology differentiated grades,platinum-based chemoradiotherapy were independent prognosis factors for cervical cancer patients(P0.05).Conclusions The peak age of cervical cancer patients in this study focus on 35-45years old which showed a single-peak.The 3-year and 5-year survivals were higher than that reported in the literature.Histology differentiated grades,platinum-based chemoradiotherapy were independent prognosis factors for cervical cancer patients.
出处 《中国妇产科临床杂志》 2013年第5期399-402,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 宫颈癌 临床特点 高危因素 预后 cervical cancer clinical characteristics risk factors prognosis
  • 相关文献

参考文献13

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CACancer J Clin, 2010,60: 277 - 300.
  • 2Kamangar F, Dores GM, Anderson WF. Patterns of cancerincidencer, mortallity, and prevalence across five continents:defining priorities to reduce cancer disparities in different geo-graphic regions of the world. J Clin Oncol,2006,24: 2137 -2150.
  • 3田卫红,张延曙,林丽红,李秀芳.宫颈癌术前新辅助化疗的临床疗效观察[J].肿瘤基础与临床,2010,23(1):30-31. 被引量:17
  • 4Park JY, Kim DY, Kim JH, et al. Further stratification ofrisk groups in patients with lymph node metastasis after radi-cal hysterectomy for early - stage cervical cancer. GynecologicOncology, 2010, 117: 53 - 58.
  • 5Dargent D, Martin X,Sacchetoni A, et al. Laparoscopic vaginalradical trachelectomy: a treatment to preserve the fertility of cer-vical carcinoma patients. Cancer, 2000,88: 18 - 77.
  • 6Horn LC,Fischer U,Raptis Q,et al. Tumor size is of prog-nostic value in surgically treated FIGO stage H cervical cancer.Gynecologic Oncology, 2007,107: 310 - 315.
  • 7Lee KB, Lee JM,Park CY,et al. What is the difference be-tween squamous cell carcinoma and adenocarcinoma of thecervix: A matched case control study. Int J Gynecol Cancer,2006, 16: 156 - 157.
  • 8GienLT,Beauchemin MC, Thomas G. Adenocarcinoma : aunique cervical cancer. Gynecol Oncol, 2010,116 : 140 -146.
  • 9GalicV,Herzog TJ, Lewin SN, et al. Prognostic significanceof adenocarcinoma histology in women with cervical cancer.Gynecologic Oncology, 2012, 125 : 287 - 291.
  • 10袁晓雁,郭社珂,崔文华.影响宫颈癌患者预后因素的临床分析[J].实用医药杂志,2007,24(2):162-163. 被引量:10

二级参考文献6

共引文献25

同被引文献30

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部